Practical reading from Professor Paul Lee and the Lincolnshire Hip Clinic team — across hip replacement, Arthrosamid, ChondroFiller, PRP and the wider world of hip and groin pain.
Without pre-treatment MRI, ChondroFiller cannot be safely injected: there is no confirmed target, no assessment of background degeneration, and no visibility of hip anatomy that might need concurrent correction.
Hip replacement outcomes at ten years are equivalent between the direct anterior and posterior surgical approaches, although the anterior method offers faster early recovery; direct anterior remains rare in the UK, adopted by fewer than 5% of surgeons, and carries a learning curve for surgeons new to the technique.
Patients with weak hip muscles entering hip replacement surgery are five times more likely to need ongoing assistance with everyday activities two years later, evidence that has reframed the pre-surgical weeks as decisive for long-term independence.
ChondroFiller delivers a Type I collagen scaffold via ultrasound-guided injection to initiate matrix-induced chondrogenesis: the patient's progenitor cells migrate into the defect and rebuild cartilage over 12–24 months. Most patients walk out the same day.
SPAIRE hip replacement preserves and repairs the posterior rotator muscles during surgery, restoring structural stability and eliminating the post-operative movement restrictions that conventional approaches require.
ChondroFiller is an injectable collagen scaffold for focal hip cartilage defects that recruits the patient's own progenitor cells to generate repair tissue without surgery or general anaesthetic.
An injected collagen scaffold recruits the patient's own progenitor cells to regenerate focal hip cartilage defects, producing hyaline-like tissue rather than the fibrocartilage scarring from microfracture repair — but only in younger, active adults without advanced joint degeneration.
Hip arthroscopy recovery for FAI and labral repair spans 4–6 months to unrestricted activity, progressing through four phases determined by measurable markers — pain, gait quality, strength symmetry — rather than calendar weeks.
Steroid injections for greater trochanteric pain syndrome target the trochanteric bursa and nearby tendons, not the hip joint, and are used as a second-line, short-term pain reliever to help rehabilitation continue when exercises and load management have not enough eased symptoms.
Lincolnshire Hip Clinic
Led by Professor Paul Lee
Start with a free, non-medical discovery call with our team. We will tell you, honestly, which of our pathways — surgical or non-surgical — fits your situation. No GP referral, no pressure to proceed.
What we offer
